The IUPHAR Committee on Receptor Nomenclature and Drug Classification (NC-IUPHAR) regularly publishes review articles and commentaries on varied topics in pharmacology. NC-IUPHAR nomenclature reports are published in the journal Pharmacological Reviews, and, since 2011, NC-IUPHAR also publishes reviews on other subjects in the British Journal of Pharmacology.

Other articles by NC-IUPHAR or database team members are sometimes published in other journals and we maintain a list of relevant articles below. Database articles describing the IUPHAR/BPS Guide to PHARMACOLOGY (GtoPdb) and its previous incarnation, IUPHAR-DB, are listed at the bottom of the page.

N.B. A general PubMed query with the keywords International[Title] AND Union[Title] AND Pharmacology[Title] returns some additional IUPHAR publications in other journals, most of which are attributable to the IUPHAR Clinical Pharmacology Section.

The publication list below is updated as new articles are published.

IUPHAR has a longstanding, formal collaboration with Pharmacological Reviews. The official nomenclature reports from the IUPHAR Committee on Receptor Nomenclature and Drug Classification (NC-IUPHAR) are published in the journal.

A PubMed list of NC-IUPHAR's publications in Pharmacological Reviews may be retrieved with the following query:

(International[Title] AND Union[Title] AND Pharmacology[Title] AND "Pharmacol Rev"[Journal]) OR 1438521[uid] OR 1332082[uid] OR 7938164[uid] OR 16382097[uid] OR 17132848[uid]

Note that some of the early publications (1992-94) do not include the words 'International Union of Pharmacology' in the article title, and therefore need to be specified by their PubMed IDs in order to retrieve a complete set. A small number of the articles listed below (e.g. forewords and editorials for IUPHAR compendia) are not found in PubMed.

2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1992

2023

Burris TP, de Vera IMS, Cote I, Flaveny CA, Wanninayake US, Chatterjee A, Walker JK, Steinauer N, Zhang J, Coons LA, Korach KS, Cain DW, Hollenberg AN, Webb P, Forrest D, Jetten AM, Edwards DP, Grimm SL, Hartig S, Lange CA, Richer JK, Sartorius CA, Tetel M, Billon C, Elgendy B, Hegazy L, Griffett K, Peinetti N, Burnstein KL, Hughes TS, Sitaula S, Stayrook KR, Culver A, Murray MH, Finck BN, Cidlowski JA (2023) International Union of Basic and Clinical Pharmacology. CXIII: Nuclear Receptor Superfamily - Update 2023. Pharmacol Rev. PHARMREV-INR-2021-000436. doi: 10.1124/pharmrev.121.000436. Online ahead of print. [PMID:37586884]

2022

IJzerman AP, Jacobson KA, Müller CE, Cronstein BN, Cunha RA (2022) International Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update. Pharmacol Rev. 74: 340-372. [PMID:35302044]

2021

Gregory KJ, Goudet C (2021) International Union of Basic and Clinical Pharmacology. CXI. Pharmacology, Signaling, and Physiology of Metabotropic Glutamate Receptors. Pharmacol Rev. 73: 521-569. [PMID:33361406]

Barnes NM, Ahern GP, Becamel C, Bockaert J, Camilleri M, Chaumont-Dubel S, Claeysen S, Cunningham KA, Fone KC, Gershon M, Di Giovanni G, Goodfellow NM, Halberstadt AL, Hartley RM, Hassaine G, Herrick-Davis K, Hovius R, Lacivita E, Lambe EK, Leopoldo M, Levy FO, Lummis SCR, Marin P, Maroteaux L, McCreary AC, Nelson DL, Neumaier JF, Newman-Tancredi A, Nury H, Roberts A, Roth BL, Roumier A, Sanger GJ, Teitler M, Sharp T, Villalón CM, Vogel H, Watts SW, Hoyer D (2021) International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function. Pharmacol Rev. 73: 310-520. [PMID:33370241]

2020

Norel X, Sugimoto Y, Ozen G, Abdelazeem H, Amgoud Y, Bouhadoun A, Bassiouni W, Goepp M, Mani S, Manikpurage HD, Senbel A, Longrois D, Heinemann A, Yao C, Clapp LH (2020) International Union of Basic and Clinical Pharmacology. CIX. Differences and Similarities between Human and Rodent Prostaglandin E 2 Receptors (EP1-4) and Prostacyclin Receptor (IP): Specific Roles in Pathophysiologic Conditions. Pharmacol Rev. 72: 910-968. [PMID:32962984]

Leach K, Hannan FM, Josephs TM, Keller AN, Møller TC, Ward DT, Kallay E, Mason RS, Thakker RV, Riccardi D, Conigrave AD, Bräuner-Osborne H (2020) International Union of Basic and Clinical Pharmacology. CVIII. Calcium-Sensing Receptor Nomenclature, Pharmacology, and Function. Pharmacol Rev. 72: 558-604. [PMID:32467152]

2019

Read C, Nyimanu D, Williams TL, Huggins DJ, Sulentic P, Macrae RGC, Yang P, Glen RC, Maguire JJ and Davenport AP (2019) International Union of Basic and Clinical Pharmacology. CVII. Structure and Pharmacology of the Apelin Receptor with a Recommendation that Elabela/Toddler Is a Second Endogenous Peptide Ligand. Pharmacol Rev. 71: 764-502. [PMID:31492821]

2018

Sieghart W & Savić MM. (2018) International Union of Basic and Clinical Pharmacology. CVI: GABA_A Receptor Subtype- and Function-selective Ligands: Key Issues in Translation to Humans. Pharmacol Rev. 70: 836-878. [PMID:30275042]

Gunther T, Tulipano G, Dournaud P, Bousquet C, Csaba Z, Kreienkamp H-J, Lupp A, Korbonits M, Castaño JP, Wester H-J, Culler M, Melmed S and Schulz S. (2018) International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature. Pharmacol Rev. 70: 763-835. [PMID:30232095]

Caraci F, Calabrese F, Molteni R, Bartova L, Dold M, Leggio GM, Fabbri C, Mendlewicz J, Racagni G, Kasper S, Riva MA, Drago F. (2018) International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets. Pharmacol Rev. 70: 475-504. [PMID:29884653]

Kennedy AJ, Davenport AP. (2018) International Union of Basic and Clinical Pharmacology. CIII. Chemerin Receptors CMKLR1 (Chemerin₁) and GPR1 (Chemerin₂) Nomenclature, Pharmacology, and Function. Pharmacol Rev. 70: 174-196. [PMID:29279348]

2017

Szabo C, Papapetropoulos A. (2017) International Union of Basic and Clinical Pharmacology. CII. Pharmacological Modulation of H₂S Levels: H₂S Donors and H₂S Biosynthesis Inhibitors. Pharmacol Rev. 69: 497-564. [PMID:28978633]

Dessauer CW, Watts VJ, Ostrom RS, Conti M, Dove S, Seifert R. (2017) International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases. Pharmacol Rev. 69: 93-139. [PMID:28255005]

Kaczmarek LK, Aldrich RW, Chandy CG, Grissmer S, Wei AD, Wulff H. (2017) International Union of Basic and Clinical Pharmacology. C. Nomenclature and Properties of Calcium-Activated and Sodium-Activated Potassium Channels. Pharmacol Rev. 69: 1-11. [PMID:28267675]

2015

Karnik SS, Unal H, Kemp JR, Tirupula KC, Eguchi S, Vanderheyden PM, Thomas WG. (2015) International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli. Pharmacol Rev. 67: 754-819. [PMID:26315714]

Panula P, Chazot PL, Cowart M, Gutzmer R, Leurs R, Liu WLS, Stark H, Thurmond RL, Haas HL. (2015) International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors. Pharmacol Rev. 67: 601-55. [PMID:26084539]

Prossnitz ER, Arterburn JB. (2015) International Union of Basic and Clinical Pharmacology. XCVII. G Protein-Coupled Estrogen Receptor and Its Pharmacologic Modulators. Pharmacol Rev. 67: 505-40. [PMID:26023144]

Bryant CE, Orr S, Ferguson B, Symmons MF, Boyle JP, and Monie TP. (2015) International Union of Basic and Clinical Pharmacology. XCVI. Pattern Recognition Receptors in Health and Disease. Pharmacol Rev. 67: 462-504. [PMID:25829385]

Halls ML, Bathgate RA, Sutton SW, Dschietzig TB, Summers RJ. (2015) International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides. Pharmacol Rev. 67: 389-440. [PMID:25761609]

Hamann J, Aust G, Araç D, Engel FB, Formstone C, Fredriksson R, Hall RA, Harty BL, Kirchhoff C, Knapp B, Krishnan A, Liebscher I, Lin HH, Martinelli DC, Monk KR, Peeters MC, Piao X, Prömel S, Schöneberg T, Schwartz TW, Singer K, Stacey M, Ushkaryov YA, Vallon M, Wolfrum U, Wright MW, Xu L, Langenhan T, Schiöth HB. (2015) International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G Protein-Coupled Receptors. Pharmacol Rev. 67: 338-67. [PMID:25713288]

Gardella TJ, Vilardaga JP. (2015) International Union of Basic and Clinical Pharmacology. XCIII. The Parathyroid Hormone Receptors-Family B G Protein-Coupled Receptors. Pharmacol Rev. 67: 310-37. [PMID:25713287]

Vaudry H, Leprince J, Chatenet D, Fournier A, Lambert DG, Le Mével JC, Ohlstein EH, Schwertani A, Tostivint H, Vaudry D. (2015) International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, urotensin II-related peptide, and their receptor: from structure to function. Pharmacol Rev. 67: 214-58. [PMID:25535277]

Kellenberger S, Schild L. (2015) International Union of Basic and Clinical Pharmacology. XCI. Structure, Function, and Pharmacology of Acid-Sensing Ion Channels and the Epithelial Na+ Channel. Pharmacol Rev. 67: 1-35. [PMID:25287517]

2014

Christopoulos A, Changeux J-P, Catterall WA, Fabbro D, Burris TP, Cidlowski JA, Olsen RW, Peters JA, Neubig RR, Pin J-P, Sexton PM, Kenakin TP, Ehlert FJ, Spedding M, Langmead CJ. (2014) International Union of Basic and Clinical Pharmacology. XC. Multisite Pharmacology: Recommendations for the Nomenclature of Receptor Allosterism and Allosteric Ligands. Pharmacol Rev. 66: 918-947. [PMID:25026896]

Bachelerie F, Ben-Baruch A, Burkhardt AM, Combadiere C, Farber JM, Graham GJ, Horuk R, Sparre-Ulrich AH, Locati M, Luster AD, Mantovani A, Matsushima K, Murphy PM, Nibbs R, Nomiyama H, Power CA, Proudfoot AE, Rosenkilde MM, Rot A, Sozzani S, Thelen M, Yoshie O, Zlotnik A. (2014) International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors. Pharmacol Rev. 66: 1-79. [PMID:24218476]

2013

Davenport AP, Alexander SP, Sharman JL, Pawson AJ, Benson HE, Monaghan AE, Liew WC, Mpamhanga CP, Bonner TI, Neubig RR, Pin JP, Spedding M, Harmar AJ. (2013) International Union of Basic and Clinical Pharmacology. LXXXVIII. G Protein-Coupled Receptor List: Recommendations for New Pairings with Cognate Ligands. Pharmacol Rev. 65: 967-86. [PMID:23686350]

Klos A, Wende E, Wareham KJ, Monk PN. (2013) International Union of Basic and Clinical Pharmacology. LXXXVII. Complement Peptide C5a, C4a, and C3a Receptors. Pharmacol Rev. 65: 500-543. [PMID:23383423]

2012

Gotter AL, Webber AL, Coleman PJ, Renger JJ, Winrow CJ. (2012) International Union of Basic and Clinical Pharmacology. LXXXVI. Orexin Receptor Function, Nomenclature and Pharmacology. Pharmacol Rev. 64: 389-420. [PMID:22759794]

Huang F, Wong X, Jan LY. (2012) International Union of Basic and Clinical Pharmacology. LXXXV. Calcium-Activated Chloride Channels. Pharmacol Rev. 64: 1-15. [PMID:22090471]

2011

Bäck M, Dahlén SE, Drazen JM, Evans JF, Serhan CN, Shimizu T, Yokomizo T, Rovati GE. (2011) International union of basic and clinical pharmacology. LXXXIV. leukotriene receptor nomenclature, distribution, and pathophysiological functions. Pharmacol Rev. 63: 539-584. [PMID:21771892]

Woodward DF, Jones RL, Narumiya S. (2011) International union of basic and clinical pharmacology. LXXXIII. classification of prostanoid receptors, updating 15 years of progress. Pharmacol Rev. 63: 471-538. [PMID:21752876]

Offermanns S, Colletti SL, Lovenberg TW, Semple G, Wise A, IJzerman AP. (2011) International Union of Basic and Clinical Pharmacology. LXXXII. Nomenclature and Classification of Hydroxy-carboxylic Acid Receptors (GPR81, GPR109A, and GPR109B). Pharmacol Rev. 63: 269-290. [PMID:21454438]

Fredholm BB, IJzerman AP, Jacobson KA, Linden J, Müller CE. (2011) International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An Update. Pharmacol Rev. 63:1-34 [PMID:21303899]

2010

Schulte G. (2010) International Union of Basic and Clinical Pharmacology. LXXX. The Class Frizzled Receptors. Pharmacol Rev 62:632-667. [PMID:21079039]

Pertwee RG, Howlett AC, Abood ME, Alexander SP, Di Marzo V, Elphick MR, Greasley PJ, Hansen HS, Kunos G, Mackie K, Mechoulam R, Ross RA. (2010) International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2. Pharmacol Rev. 62:588-631. [PMID:21079038]

Chun J, Hla T, Lynch KR, Spiegel S, Moolenaar WH. (2010) International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid Receptor Nomenclature. Pharmacol Rev. 62:579-587. [PMID:21079037]

Kirby HR, Maguire JJ, Colledge WH, Davenport AP. (2010) International Union of Basic and Clinical Pharmacology. LXXVII. Kisspeptin Receptor Nomenclature, Distribution, and Function. Pharmacol Rev. 62: 565-578. [PMID:21079036]

Wu LJ, Sweet TB, Clapham DE. (2010) International Union of Basic and Clinical Pharmacology. LXXVI. Current progress in the mammalian TRP ion channel family. Pharmacol Rev. 62: 381-404. [PMID:20716668]

Dubocovich ML, Delagrange P, Krause DN, Sugden D, Cardinali DP, Olcese J. (2010) International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors. Pharmacol Rev. 62: 343-380. [PMID:20605968]

Pitkin SL, Maguire JJ, Bonner TI, Davenport AP. (2010) International Union of Basic and Clinical Pharmacology. LXXIV. Apelin Receptor Nomenclature, Distribution, Pharmacology, and Function. Pharmacol Rev. 62: 331-342. [PMID:20605969]

2009

Ye RD, Boulay F, Wang JM, Dahlgren C, Gerard C, Parmentier M, Serhan CN, Murphy PM. (2009) International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family. Pharmacol Rev. 61: 119-161. [PMID:19498085]

Maguire JJ, Parker WA, Foord SM, Bonner TI, Neubig RR, Davenport AP. (2009) International Union of Pharmacology. LXXII. Recommendations for Trace Amine Receptor Nomenclature. Pharmacol Rev. 61: 1-8. [PMID:19325074]

2008

Stoddart LA, Smith NJ, Milligan G. (2008) International Union of Pharmacology. LXXI. Free Fatty Acid Receptors FFA1, -2, and -3: Pharmacology and Pathophysiological Functions. Pharmacol Rev. 60: 405-417. [PMID:19047536]

Olsen RW, Sieghart W. (2008) International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid_A receptors: classification on the basis of subunit composition, pharmacology, and function. Update. Pharmacol Rev. 60: 243-260. [PMID:18790874]

Hay DL, Poyner DR, Quirion R. (2008) International Union of Basic and Clinical Pharmacology. LXIX. Status of the Calcitonin Gene-Related Peptide Subtype 2 Receptor. Pharmacol Rev. 60: 143-145. [PMID:18552275]

Jensen RT, Battey JF, Spindel ER, Benya RV. (2008) International Union of Basic and Clinical Pharmacology. LXVIII. Mammalian Bombesin Receptors: Nomenclature, Distribution, Pharmacology, Signaling, and Functions in Normal and Disease States. Pharmacol Rev. 60: 1-42. [PMID:18055507]

2007

Pin JP, Neubig R, Bouvier M, Devi L, Filizola M, Javitch JA, Lohse MJ, Milligan G, Palczewski K, Parmentier M, Spedding M. (2007) International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the Recognition and Nomenclature of G Protein-Coupled Receptor Heteromultimers. Pharmacol Rev. 59: 5-13. [PMID:17329545]

2006

Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Knight GE, Fumagalli M, Gachet C, Jacobson KA, Weisman GA. (2006) International Union of Pharmacology. LVIII. Update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev. 58: 281-341. [PMID:16968944]

Bathgate RA, Ivell R, Sanborn BM, Sherwood OD, Summers RJ. (2006) International Union of Pharmacology. LVII. Recommendations for the Nomenclature of Receptors for Relaxin Family Peptides. Pharmacol Rev. 58: 7-31. [PMID:16507880]

IUPHAR Compendium of the Pharmacology and Classification of the Nuclear Receptor Superfamily 2006

Laudet V, Spedding M. (2006) Foreword. Pharmacol Rev. 58: 684.

Germain P, Staels B, Dacquet C, Spedding M, Laudet V. (2006) Overview of Nomenclature of Nuclear Receptors. Pharmacol Rev. 58: 685-704. [PMID:17132848]

Flamant F, Baxter JD, Forrest D, Refetoff S, Samuels H, Scanlan TS, Vennström B, Samarut J. (2006) International Union of Pharmacology. LIX. The Pharmacology and Classification of the Nuclear Receptor Superfamily: Thyroid Hormone Receptors. Pharmacol Rev. 58: 705-711. [PMID:17132849]

Germain P, Chambon P, Eichele G, Evans RM, Lazar MA, Leid M, De Lera AR, Lotan R, Mangelsdorf DJ, Gronemeyer H. (2006) International Union of Pharmacology. LX. Retinoic Acid Receptors. Pharmacol Rev. 58: 712-725. [PMID:17132850]

Michalik L, Auwerx J, Berger JP, Chatterjee VK, Glass CK, Gonzalez FJ, Grimaldi PA, Kadowaki T, Lazar MA, O'Rahilly S, Palmer CN, Plutzky J, Reddy JK, Spiegelman BM, Staels B, Wahli W. (2006) International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors. Pharmacol Rev. 58: 726-741. [PMID:17132851]

Moore DD, Kato S, Xie W, Mangelsdorf DJ, Schmidt DR, Xiao R, Kliewer SA. (2006) International Union of Pharmacology. LXII. The NR1H and NR1I Receptors: Constitutive Androstane Receptor, Pregnene X Receptor, Farnesoid X Receptor α, Farnesoid X Receptor β, Liver X Receptor α, Liver X Receptor β, and Vitamin D Receptor. Pharmacol Rev. 58: 742-759. [PMID:17132852]

Germain P, Chambon P, Eichele G, Evans RM, Lazar MA, Leid M, De Lera AR, Lotan R, Mangelsdorf DJ, Gronemeyer H. (2006) International Union of Pharmacology. LXIII. Retinoid X Receptors. Pharmacol Rev. 2006 58: 760-772. [PMID:17132853]

Dahlman-Wright K, Cavailles V, Fuqua SA, Jordan VC, Katzenellenbogen JA, Korach KS, Maggi A, Muramatsu M, Parker MG, Gustafsson JA. (2006) International Union of Pharmacology. LXIV. Estrogen Receptors. Pharmacol Rev. 58: 773-781. [PMID:17132854]

Lu NZ, Wardell SE, Burnstein KL, Defranco D, Fuller PJ, Giguere V, Hochberg RB, McKay L, Renoir JM, Weigel NL, Wilson EM, McDonnell DP, Cidlowski JA. (2006) International Union of Pharmacology. LXV. The Pharmacology and Classification of the Nuclear Receptor Superfamily: Glucocorticoid, Mineralocorticoid, Progesterone, and Androgen Receptors. Pharmacol Rev. 58: 782-797. [PMID:17132855]

Benoit G, Cooney A, Giguere V, Ingraham H, Lazar M, Muscat G, Perlmann T, Renaud JP, Schwabe J, Sladek F, Tsai MJ, Laudet V. (2006) International Union of Pharmacology. LXVI. Orphan Nuclear Receptors. Pharmacol Rev. 58: 798-836. [PMID:17132856]

2005

Davenport AP, Bonner TI, Foord SM, Harmar AJ, Neubig RR, Pin JP, Spedding M, Kojima M, Kangawa K. (2005) International Union of Pharmacology. LVI. Ghrelin Receptor Nomenclature, Distribution, and Function. Pharmacol Rev. 57: 541-546. [PMID:16382107]

Foord SM, Bonner TI, Neubig RR, Rosser EM, Pin JP, Davenport AP, Spedding M, Harmar AJ. (2005) International Union of Pharmacology. XLVI. G Protein-Coupled Receptor List. Pharmacol Rev. 57: 279-88. [PMID:15914470]

Leeb-Lundberg LM, Marceau F, Müller-Esterl W, Pettibone DJ, Zuraw BL. (2005) International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences. Pharmacol Rev. 57: 27-77. [PMID:15734727]

IUPHAR Compendium of Voltage-Gated Ion Channels 2005

Catterall WA, Gutman GA. (2005) Introduction to the IUPHAR Compendium of Voltage-Gated Ion Channels 2005. Pharmacol Rev. 57: 385.

Yu FH, Yarov-Yarovoy V, Gutman GA, Catterall WA. (2005) Overview of Molecular Relationships in the Voltage-Gated Ion Channel Superfamily. Pharmacol Rev. 57: 387-395. [PMID:16382097]

Catterall WA, Goldin AL, Waxman SG. (2005) International Union of Pharmacology. XLVII. Nomenclature and Structure-Function Relationships of Voltage-Gated Sodium Channels. Pharmacol Rev. 57: 397-409. [PMID:16382098]

Catterall WA, Perez-Reyes E, Snutch TP, Striessnig J. (2005) International Union of Pharmacology. XLVIII. Nomenclature and Structure-Function Relationships of Voltage-Gated Calcium Channels. Pharmacol Rev. 57: 411-425. [PMID:16382099]

Clapham DE, Julius D, Montell C, Schultz G. (2005) International Union of Pharmacology. XLIX. Nomenclature and Structure-Function Relationships of Transient Receptor Potential Channels. Pharmacol Rev. 57: 427-450. [PMID:16382100]

Clapham DE, Garbers DL. (2005) International Union of Pharmacology. L. Nomenclature and Structure-Function Relationships of CatSper and Two-Pore Channels. Pharmacol Rev. 57: 451-454. [PMID:16382101]

Hofmann F, Biel M, Kaupp UB. (2005) International Union of Pharmacology. LI. Nomenclature and Structure-Function Relationships of Cyclic Nucleotide-Regulated Channels. Pharmacol Rev. 57: 455-462. [PMID:16382102]

Wei AD, Gutman GA, Aldrich R, Chandy KG, Grissmer S, Wulff H. (2005) International Union of Pharmacology. LII. Nomenclature and Molecular Relationships of Calcium-Activated Potassium Channels. Pharmacol Rev. 57: 463-472. [PMID:16382103]

Gutman GA, Chandy KG, Grissmer S, Lazdunski M, McKinnon D, Pardo LA, Robertson GA, Rudy B, Sanguinetti MC, Stühmer W, Wang X. (2005) International Union of Pharmacology. LIII. Nomenclature and Molecular Relationships of Voltage-Gated Potassium Channels. Pharmacol Rev. 57: 473-508. [PMID:16382104]

Kubo Y, Adelman JP, Clapham DE, Jan LY, Karschin A, Kurachi Y, Lazdunski M, Nichols CG, Seino S, Vandenberg CA. (2005) International Union of Pharmacology. LIV. Nomenclature and Molecular Relationships of Inwardly Rectifying Potassium Channels. Pharmacol Rev. 57: 509-526. [PMID:16382105]

Goldstein SA, Bayliss DA, Kim D, Lesage F, Plant LD, Rajan S. (2005) International Union of Pharmacology. LV. Nomenclature and Molecular Relationships of Two-P Potassium Channels. Pharmacol Rev. 57: 527-540. [PMID:16382106]

2004

Brink C, Dahlén SE, Drazen J, Evans JF, Hay DW, Rovati GE, Serhan CN, Shimizu T, Yokomizo T. (2004) International Union of Pharmacology XLIV. Nomenclature for the Oxoeicosanoid Receptor. Pharmacol Rev. 56: 149-157. [PMID:15001665]

2003

Neubig RR, Spedding M, Kenakin T, Christopoulos A. (2003) International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on Terms and Symbols in Quantitative Pharmacology. Pharmacol Rev. 55: 597-606. [PMID:14657418]

Brink C, Dahlén SE, Drazen J, Evans JF, Hay DW, Nicosia S, Serhan CN, Shimizu T, Yokomizo T. (2003) International Union of Pharmacology XXXVII. Nomenclature for Leukotriene and Lipoxin Receptors. Pharmacol Rev. 55: 195-227. [PMID:12615958]

Mayo KE, Miller LJ, Bataille D, Dalle S, Göke B, Thorens B, Drucker DJ. (2003) International Union of Pharmacology. XXXV. The Glucagon Receptor Family. Pharmacol Rev. 55: 167-194. [PMID:12615957]

Hauger RL, Grigoriadis DE, Dallman MF, Plotsky PM, Vale WW, Dautzenberg FM. (2003) International Union of Pharmacology. XXXVI. Current Status of the Nomenclature for Receptors for Corticotropin-Releasing Factor and Their Ligands. Pharmacol Rev. 55: 21-26. [PMID:12615952]

IUPHAR Compendium of Voltage-Gated Ion Channels 2003

Catterall WA, Chandy KG, Clapham DE, Gutman GA, Hofmann F, Harmar AJ , Abernethy DR, Spedding M. (2003) International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels. Pharmacol Rev. 55: 573-574.

Catterall WA, Goldin AL, Waxman SG. (2003) International Union of Pharmacology. XXXIX. Compendium of Voltage-Gated Ion Channels: Sodium Channels. Pharmacol Rev. 55: 575-578. [PMID:14657413]

Catterall WA, Striessnig J, Snutch TP, Perez-Reyes E. (2003) International Union of Pharmacology. XL. Compendium of Voltage-Gated Ion Channels: Calcium Channels. Pharmacol Rev. 55: 579-581. [PMID:14657414]

Gutman GA, Chandy KG, Adelman JP, Aiyar J, Bayliss DA, Clapham DE, Covarriubias M, Desir GV, Furuichi K, Ganetzky B, Garcia ML, Grissmer S, Jan LY, Karschin A, Kim D, Kuperschmidt S, Kurachi Y, Lazdunski M, Lesage F, Lester HA, McKinnon D, Nichols CG, et al. (2003) International Union of Pharmacology. XLI. Compendium of Voltage-Gated Ion Channels: Potassium Channels. Pharmacol Rev. 55: 583-586. [PMID:14657415]

Hofmann F, Biel M, Kaupp UB. (2003) International Union of Pharmacology. XLII. Compendium of Voltage-Gated Ion Channels: Cyclic Nucleotide-Modulated Channels. Pharmacol Rev. 55: 587-589. [PMID:14657416]

Clapham DE, Montell C, Schultz G, Julius D. (2003) International Union of Pharmacology. XLIII. Compendium of Voltage-Gated Ion Channels: Transient Receptor Potential Channels. Pharmacol Rev. 55: 591-596. [PMID:14657417]

2002

Chun J, Goetzl EJ, Hla T, Igarashi Y, Lynch KR, Moolenaar W, Pyne S, Tigyi G. (2002) International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature. Pharmacol Rev. 54: 265-270. [PMID:12037142]

Bowery NG, Bettler B, Froestl W, Gallagher JP, Marshall F, Raiteri M, Bonner TI, Enna SJ. (2002) International Union of Pharmacology. XXXIII. Mammalian GABAB receptors: Structure and function. Pharmacol Rev. 54: 247-264. [PMID:12037141]

Poyner DR, Sexton PM, Marshall I, Smith DM, Quirion R, Born W, Muff R, Fischer JA, Foord SM. (2002) International Union of Pharmacology. XXXII. The mammalian CGRP, adrenomedullin, amylin and calcitonin receptors. Pharmacol Rev. 54: 233-246. [PMID:12037140]

Spedding M, Bonner TI, Watson SP. (2002) International Union of Pharmacology. XXXI. Recommendations for the nomenclature of multimeric, G protein-coupled receptors. Pharmacol Rev. 54: 231-232. [PMID:12037139]

Murphy PM. (2002) International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature. Pharmacol Rev. 54: 227-230. [PMID:12037138]

Davenport AP. (2002) International Union of Pharmacology. XXIX. Update on endothelin receptor nomenclature. Pharmacol Rev. 54: 219-226. [PMID:12037137]

Hollenberg MD, Compton SJ. (2002) International Union of Pharmacology. XXVIII. Proteinase-activated receptors. Pharmacol Rev. 54: 203-218. [PMID:12037136]

Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG. (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev. 54: 161-202. [PMID:12037135]

Abernathy DR, Ruffolo RR Jr. (2002) International Union of Pharmacology. XXVI. Nomenclature and Pharmacological Reviews. Pharmacol Rev. 54: 159.

2001

Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J. (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev. 53: 527-552. [PMID:111734617]

Khakh BS, Burnstock G, Kennedy C, King BF, North RA, Séguéla P, Voigt M, Humphrey PP. (2001) International Union of Pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev. 53: 107-118. [PMID:11171941]

2000

de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. (2000). International Union of Pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev. 52: 415-472. [PMID:10977869]

Murphy PM, Baggiolini M, Charo IF, Hébert CA, Horuk R, Matsushima K, Miller LH, Oppenheim JJ, Power CA. (2000). International Union of Pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev. 52: 145-176. [PMID:10699158]

1999

Noble F, Wank SA, Crawley JN, Bradwejn J, Seroogy KB, Hamon M, Roques BP. (1999) International Union of Pharmacology. XXI. Structure, distribution and functions of cholecystokinin receptors. Pharmacol Rev. 51: 745-781. [PMID:10581329]

Lukas RJ, Changeux JP, Le Novère N, Albuquerque EX, Balfour DJ, Berg DK, Bertrand D, Chiappinelli VA, Clarke PB, Collins AC, Dani JA, Grady SR, Kellar KJ, Lindstrom JM, Marks MJ, Quik M, Taylor PW, Wonnacott S. (1999) International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol Rev. 51: 397-401. [PMID:10353988]

1998

Barnard EA, Skolnick P, Olsen RW, Mohler H, Sieghart W, Biggio G, Braestrup C, Bateson AN, Langer SZ. (1998) International Union of Pharmacology. XV. Subtypes of γ-aminobutyric acid_A receptors. Classification on the basis of subunit structure and receptor function. Pharmacol Rev. 50: 291-313. [PMID:9647870]

Caulfield MP, Birdsall NJ. (1998) International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev. 50: 279-290. [PMID:9647869]

Humphrey PP, Barnard EA. (1998) International Union of Pharmacology. XIX. The IUPHAR Receptor Code: A proposal for an alphanumeric classification system. Pharmacol Rev. 50: 271-277. [PMID:9647868]

Harmar AJ, Arimura A, Gozes I, Journot L, Laburthe M, Pisegna JR, Rawlings SR, Robberecht P, Said SI, Sreedharan SP, Wank SA, Waschek JA. (1998) International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev. 50: 265-269. [PMID:9647867]

Michel MC, Beck-Sickinger A, Cox H, Doods HN, Herzog H, Larhammar D, Quirion R, Schwartz T, Westfall T. (1998) International Union of Pharmacology. XVI. Recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev. 50: 143-150. [PMID:9549761]

1997

Moncada S, Higgs A, Furchgott R. (1997) International Union of Pharmacology. XIV. Nomenclature in nitric oxide research. Pharmacol Rev. 49: 137-142. [PMID:9228663]

Hill SJ, Ganellin CR, Timmerman H, Schwartz JC, Shankley NP, Young JM, Schunack W, Levi R, Haas HL. (1997) International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev. 49: 253-278. [PMID:9311023]

1996

Dhawan BN, Cesselin F, Raghubir R, Reisine T, Bradley PB, Portoghese PS, Hamon M. (1996) International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol Rev. 48: 567-592. [PMID:8981566]

Vanhoutte PM, Humphrey PP, Spedding M. (1996) International Union of Pharmacology. XI. Recommendations for nomenclature of new receptor subtypes. Pharmacol Rev. 48: 1-2. [PMID:8685244]

1995

Hieble JP, Bylund DB, Clarke DE, Eikenburg DC, Langer SZ, Lefkowitz RJ, Minneman KP, Ruffolo RR Jr. (1995) International Union of Pharmacology. X. Recommendation for nomenclature of α₁-adrenoceptors: consensus update. Pharmacol Rev. 47: 267-270. [PMID:7568329]

Jenkinson DH, Barnard EA, Hoyer D, Humphrey PP, Leff P, Shankley NP. (1995) International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. IX. Recommendations on terms and symbols in quantitative pharmacology. Pharmacol Rev. 47: 255-265. [PMID:7568328]

1994

Coleman RA, Smith WL, Narumiya S. (1994) VIII. International Union of Pharmacology classification of prostanoid receptors: Properties, distribution and structure of the receptors and their subtypes. Pharmacol Rev. 46: 205-229. [PMID:7938166]

Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PP. (1994) VII. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev. 46: 157-203. [PMID:7938164]

Fredholm B. B., Abbracchio, M. P., Burnstock, G., Daly, J. W., Harden, T. K., Jacobson, K. A., Leff, P. and Williams, M. (1994) International Union of Pharmacology. VI. Nomenclature and classification of purinoceptors. Pharmacol Rev. 46: 143-156. [PMID:7938164]

Masaki T, Vane JR, Vanhoutte PM. (1994) International Union of Pharmacology. V. Nomenclature of endothelin receptors. Pharmacol Rev. 46: 137-142. [PMID:7938163]

Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RR Jr, Trendelenburg U. (1994) International Union of Pharmacology. IV. Nomenclature of adrenoceptors. Pharmacol Rev. 46, 121-136. [PMID:7938162]

Vanhoutte PM, Barnard EA, Cosmides GJ, Humphrey PP, Spedding M, Godfraind T. (1994) International Union of Pharmacology. I. Committee on Receptor Nomenclature and Drug Classification. Pharmacol Rev. 46: 111-116. [PMID:7938161]

1992

Spedding M, Paoletti R. (1992) International Union of Pharmacology. III. Classification of calcium channels and the sites of action of drugs modifying channel function. Pharmacol Rev. 44: 363-376. [PMID:1332082]

Kenakin TP, Bond RA, Bonner TI. (1992) International Union of Pharmacology. II. Definition of pharmacological receptors. Pharmacol Rev. 44: 351-362. [PMID:1438521]

IUPHAR has a formal collaboration with the British Journal of Pharmacology. IUPHAR review articles and editorials from NC-IUPHAR on wide-ranging topics relevant to pharmacology (excluding nomenclature articles which are published in Pharmacological Reviews) are published in the journal.

A PubMed list of NC-IUPHAR Reviews in the BJP may be retrieved with the following query terms:

IUPHAR[Title] AND review[Title] AND "British Journal of Pharmacology"[Journal]

In addition to reviews the list below includes other types of articles such as editorials and the Concise Guide to PHARMACOLOGY, which are also found in PubMed.

2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011

2023

Armstrong JF, Campo B, Alexander SPH, Arendse LB, Cheng X, Davenport AP, Faccenda E, Fidock DA, Godinez-Macias KP, Harding SD, Kato N, Lee MCS, Luth MR, Mazitschek R, Mittal N, Niles JC, Okombo J, Ottilie S, Pasaje CFA, Probst AS, Rawat M, Rocamora F, Sakata-Kato T, Southan C, Spedding M, Tye MA, Yang T, Zhao N, Davies JA. (2023) Advances in malaria pharmacology and the online guide to MALARIA PHARMACOLOGY: IUPHAR review 38 Br J Pharmacol. Online ahead of print. doi: 10.1111/bph.16144. [PMID:37197802]

2022

Borrello MT, Mann D. (2022) Chronic liver diseases: From development to novel pharmacological therapies: IUPHAR Review 37 Br J Pharmacol. Online ahead of print. doi: 10.1111/bph.15853. [PMID:35393658]

Connolly CN, Alexander SPH, Davies JA, Spedding M. (2022) Environmental pharmacology-Dosing the environment: IUPHAR review 36 Br J Pharmacol. 179(23):5172-5179. doi: 10.1111/bph.15933. [PMID:35975296]

Qin CX, Norling LV, Vecchio EA, Brennan EP, May LT, Wootten D, Godson C, Perretti M, Ritchie RH. (2022) Formylpeptide receptor 2: Nomenclature, structure, signalling and translational perspectives: IUPHAR review 35 Br J Pharmacol. doi: 10.1111/bph.15919. [PMID:35797341]

Singh KD & Karnik SS. (2022) Structural perspectives on the mechanism of signal activation, ligand selectivity and allosteric modulation in angiotensin receptors: IUPHAR Review 34 Br J Pharmacol. 179(18):4461-4472. doi: 10.1111/bph.15840. [PMID:35318654]

Sharma A, De Blasio M, Ritchie R. (2022) Current challenges in the treatment of cardiac fibrosis: Recent insights into the sex-specific differences of glucose-lowering therapies on the diabetic heart: IUPHAR Review 33 Br J Pharmacol. doi: 10.1111/bph.15820. [PMID:35174479]

Kolb P, Kenakin T, Alexander SPH, Bermudez M, Bohn LM, Breinholt CS, Bouvier M, Hill SJ, Kostenis E, Martemyanov K, Neubig RR, Onaran HO, Rajagopal S, Roth BL, Selent J, Shukla AK, Sommer ME, Gloriam DE (2022) Community Guidelines for GPCR Ligand Bias: IUPHAR Review 32 Br J Pharmacol. 179(14):3651-3674. doi: 10.1111/bph.15811. [PMID:35106752]

2021

Levi-Schaffer F, de Marco A (2021) COVID-19 and the revival of passive immunization: Antibody therapy for inhibiting SARS-CoV-2 and preventing host cell infection: IUPHAR review: 31 Br J Pharmacol. 178(17):3359-3372. doi: 10.1111/bph.15359. [PMID:33401333]

Illes P, Müller CE, Jacobson KA, Grutter T, Nicke A, Fountain SJ, Kennedy C, Schmalzing G, Jarvis MF, Stojilkovic SS, King BF, Di Virgilio F. (2021) Update of P2X receptor properties and their pharmacology: IUPHAR Review 30 Br J Pharmacol. 178(3):489-514. doi: 10.1111/bph.15299. [PMID:33125712]

2020

Alexander SPH, Armstrong J, Davenport AP, Davies JA, Faccenda E, Harding SD, Levi-Schaffer F, Maguire JJ, Pawson AJ, Southan C, Spedding MJ (2020) A rational roadmap for SARS‐CoV‐2/COVID‐19 pharmacotherapeutic research and development. IUPHAR Review 29 Br J Pharmacol. 177(21):4942-4966. doi: 10.1111/bph.15094. [PMID:32358833]

Mariotti FR, Quatrini L, Munari E, , Vacca, P., Tumino, N., Pietra, G., Mingari, M. C., & Moretta, L. (2020) Inhibitory checkpoints in human natural killer cells: IUPHAR Review 28 Br J Pharmacol. 177(13):2889-2903. doi: 10.1111/bph.15081. [PMID:32335915]

Jacobson KA, Delicado EG, Gachet C, Kennedy C, von Kügelgen I, Li B, Miras-Portugal MT, Novak I, Schöneberg T, Perez-Sen R, Thor D, Wu B, Yang Z, Müller CE (2019) Update of P2Y Receptor Pharmacology: IUPHAR Review 27. Br J Pharmacol. 177(11):2413-2433. doi: 10.1111/bph.15005. [PMID:32037507]

2019

Gada K & Plant LD. (2019) Two-pore domain potassium channels: emerging targets for novel analgesic drugs: IUPHAR Review 26 Br J Pharmacol. 176(2):256-266. doi: 10.1111/bph.14518. [PMID:30325008]

2018

Hay DL, Garelja ML, Poyner DR, Walker CS. (2018) Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25 Br J Pharmacol. 175(1):3-17. doi: 10.1111/bph.14075. [PMID:29059473]

2017

Alexander SPH, Kelly E, Marrion NV, Peters JA, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Buneman OP, Cidlowski JA, Christopoulos A, Davenport AP, Fabbro D, Spedding M, Striessnig J, Davies JA; CGTP Collaborators. (2017) The Concise Guide to PHARMACOLOGY 2017/18. Br J Pharmacol. 174 (Suppl 1): S1-S446. [PMIDs:29055037,29055040,29055033,29055038,29055036,29055035,29055034,29055039,29055032]

Leprince J, Bagnol D, Bureau R, Fukusumi S, Granata R, Hinuma S, Larhammar D, Primeaux S, Santos JSO, Tsutsui K, Ukena K, Vaudry H.(2017) The Arg-Phe-amide peptide 26RFa/QRFP and its Receptor - IUPHAR Review 24 Br J Pharmacol. 174(20):3573-3607. doi: 10.1111/bph.13907. [PMID:28613414]

Ishii M. (2017) Immunology provides a great success for treating systemic autoimmune diseases - a perspective on immunopharmacology - IUPHAR Review 23. Br J Pharmacol. 174(13):1875-1880. doi: 10.1111/bph.13784. [PMID:28299772]

Karnik SS, Khuraijam D, Tirupula K, Unal H. (2017) Significance of Ang(1-7) coupling with MAS1 and other GPCRs to the Renin-Angiotensin System: IUPHAR Review 22. Br J Pharmacol. 174: 737-753 [PMID:28194766]

Sjögren B. (2017) The evolution of RGS proteins as drug targets - 20 years in the making. IUPHAR Review 21. Br J Pharmacol. 174: 427-437 [PMID:28098342]

2016

Jockers R, Delagrange P, Dubocovich ML, Markus RP, Renault N, Tosini G, Cecon E, Zlotos DP. (2016) Update on melatonin receptors: IUPHAR Review 20. Br J Pharmacol. 173: 2702-2725 [PMID:27314810]

Boscardin E, Alijevic O, Hummler E, Frateschi S, Kellenberger S. (2016) The function and regulation of acid-sensing ion channels (ASICs) and the epithelial Na⁺ channel (ENaC): IUPHAR Review 19. Br J Pharmacol. 173: 2671-2701 [PMID:27278329]

Carvalho S, Levi-Schaffer F, Sela M, Yarden Y. (2016) Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti-cancer antibodies: IUPHAR Review 18. Br J Pharmacol. 173: 1407-1424 [PMID:26833433]

Landolina N, Levi-Schaffer F. (2016) Monoclonal antibodies: the new magic bullets for allergy: IUPHAR Review 17. Br J Pharmacol. 173: 793-803 [PMID:26620589]

2015

Alexander SPH, Kelly E, Marrion N, Peters JA, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Southan C, Buneman OP, Catterall WA, Cidlowski JA, Davenport AP, Fabbro D, Fan G, McGrath JC, Spedding M, Davies JA; CGTP Collaborators. (2015) The Concise Guide to PHARMACOLOGY 2015/16. Br J Pharmacol. 172: 5729-6202. [PMIDs:26650438,26650439,26650440,26650441,26650442,26650443,26650444,26650445,26650446]

Tiligada E, Ishii M, Riccardi C, Spedding M, Simon HU, Teixeira MM, Cuervo ML, Holgate ST, Levi-Schaffer F. (2015) The expanding role of immunopharmacology - IUPHAR Review 16. Br J Pharmacol. 172: 4217–27. [PMID:26173913]

McGrath JC, Pawson AJ, Sharman JL, Alexander SP. (2015) BJP is linking its articles to the IUPHAR/BPS Guide to PHARMACOLOGY. Br J Pharmacol. 172: 2929–32 [PMID:25965085]

Bachelerie F, Graham GJ, Locati M, Mantovani A, Murphy PM, Nibbs R, Rot A, Sozzani S, Thelen M. (2015) An atypical addition to the chemokine receptor nomenclature: IUPHAR Review 15. Br J Pharmacol. 172: 3945-9 [Epub ahead of print] [PMID:25958743]

Fabbro D, Cowan-Jacob SW, Moebitz H. (2015)10 things you should know about protein kinases: IUPHAR Review 14. Br J Pharmacol. 172: 2675–700 [PMID:25630872]

2014

Beaulieu J-M, Espinoza S, Gainetdinov RR. (2014) Dopamine receptors: an update – IUPHAR Review 13. Br J Pharmacol. 172: 1-23. [PMID:25671228]

Maguire JJ, Davenport AP. (2014) Endothelin@25 – new agonists, antagonists, inhibitors and emerging research frontiers: IUPHAR Review 12. Br J Pharmacol. 171: 5555–72. [PMID:25131455]

Tough DF, Lewis HD, Rioja I, Lindon MJ, Prinjha RK. (2014) Epigenetic pathway targets for the treatment of disease: accelerating progress in the development of pharmacological tools: IUPHAR Review 11. Br J Pharmacol. 171: 4981–5010. [PMID:25060293]

Fujita W, Gomes I, Devi LA. (2014) Revolution in GPCR Signaling: Opioid receptor heteromers as novel therapeutic targets: IUPHAR Review 10. Br J Pharmacol. 171: 4155–76. [PMID:24916280]

Cox BM, Christie MJ, Devi L, Toll L, Traynor JR. (2014) Challenges for opioid receptor nomenclature: IUPHAR Review 9. Br J Pharmacol. 172: 317–23 [PMID:24528283]

Kihara Y, Maceyka M, Spiegel S, Chun J. (2014) Lysophospholipid receptor nomenclature review: IUPHAR Review 8. Br J Pharmacol. 171: 3575–94. [PMID:24602016]

Bäck M, Powell WS, Dahlén SE, Drazen JM, Evans JF, Serhan CN, Shimizu T, Yokomizo T, Rovati GE. (2014) International Union of Basic and Clinical Pharmacology. Update on Leukotriene, Lipoxin and Oxoeicosanoid Receptors: IUPHAR Review 7. Br J Pharmacol. 171: 3551–74. [PMID:24588652]

Dollery CT. (2014) Lost in Translation (LiT): IUPHAR Review 6. Br J Pharmacol. 171: 2269–90. [PMID:24428732]

Schulz S, Lehmann A, Kliewer A, Nagel F. (2014) Fine-tuning somatostatin receptor signalling by agonist-selective phosphorylation and dephosphorylation: IUPHAR Review 5. Br J Pharmacol. 171: 1591-9. [PMID:24328848]

Bonner TI. (2014) Should pharmacologists care about alternative splicing? IUPHAR Review 4. Br J Pharmacol. 171: 1231–40. [PMID:24670145]

Dijksterhuis JP, Petersen J, Schulte G. (2014) WNT/Frizzled signalling: receptor–ligand selectivity with focus on FZD-G protein signalling and its physiological relevance: IUPHAR Review 3. Br J Pharmacol. 171: 1195–1209. [PMID:24032637]

2013

Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, McGrath JC, Catterall WA, Spedding M, Peters JA and Harmar AJ, CGTP Collaborators. (2013) The Concise Guide to PHARMACOLOGY 2013/14. Br J Pharmacol. 170: 1449–1867. [PMIDs:24528237,24528238,24528239,24528240,24528241,24528242,24528243,24517644]

Davenport AP, Harmar AJ. (2013) Evolving pharmacology of orphan GPCRs: IUPHAR Commentary. Br J Pharmacol. 170: 693-5. [PMID:23957221]

Kenakin T. (2013) New concepts in pharmacological efficacy at 7TM receptors: IUPHAR Review 2. Br J Pharmacol. 168: 554-75. [PMID:22994528]

2012

Alexander SP, Benson HE, Davenport A, Mathie A, McGrath IJ, Pawson AJ, Peters JA, Sharman JL, Spedding M, Harmar AJ. (2012) GuideToPharmacology.org - an update. Br J Pharmacol. 167: 697-698. [PMID:23003568]

Harmar AJ, Fahrenkrug J, Gozes I, Laburthe M, May V, Pisegna JR, Vaudry D, Vaudry H, Waschek JA, Said SI. (2012) Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR Review 1. Br J Pharmacol. 166: 4-17. [PMID:22289055]

2011

Alexander S, Harmar A, McGrath I. (2011) New updated GRAC Fifth Edition with searchable online version. Launch of new portal Guide to Pharmacology in association with NC-IUPHAR. Transporter-Themed Issue. Br J Pharmacol. 164: 1749-50. [PMID:22085157]

Hoffmann M, Vander Stichele R, Bates DW, Björklund J, Alexander S, Andersson ML, Auraaen A, Bennie M, Dahl ML, Eiermann B, Hackl W, Hammar T, Hjemdahl P, Koch S, Kunnamo I, Le Louët H, Panagiotis P, Rägo L, Spedding M, Seidling HM, Demner-Fushman D, Gustafsson LL. (2020). Guiding principles for the use of knowledge bases and real-world data in clinical decision support systems: report by an international expert workshop at Karolinska Institutet Expert Rev Clin Pharmacol., 1-10 [Epub ahead of print], doi: 10.1080/17512433.2020.1805314. [PMID:32990065]

Davenport AP, Kuc RE, Southan C, Maguire JJ. (2018). New drugs and emerging therapeutic targets in the endothelin signaling pathway and prospects for personalized precision medicine. Physiol. Res., (Suppl. 1): S37-S54, doi: 10.1021/acsomega.8b00659. [PMID:29947527]

Benson H, Watterson S, Sharman J, Mpamhanga C, Parton A, Southan C, Harmar A, Ghazal P. (2017). Is systems pharmacology ready to impact upon therapy development? A study on the cholesterol biosynthesis pathway. Br J Pharmacol., doi: 10.1111/bph.14037. [Epub ahead of print] [PMID:28910500]

Babbitt PC, Bagos PG, Bairoch A, Bateman A, Chatonnet A, Chen MJ, Craik DJ, Finn RD, Gloriam D, Haft DH, Henrissat B, Holliday GL, Isberg V, Kaas Q, Landsman D, Lenfant N, Manning G, Nagano N, Srinivasan N, O'Donovan C, Pruitt KD, Sowdhamini R, Rawlings ND, Saier MH Jr, Sharman JL, Spedding M, Tsirigos KD, Vastermark A, Vriend G. (2015) Creating a specialist protein resource network: a meeting report for the protein bioinformatics and community resources retreat. Database. bav063. [PMID:26284514]

Holliday GL, Bairoch A, Bagos PG, Chatonnet A, Craik DJ, Finn RD, Henrissat B, Landsman D, Manning G, Nagano N, O'Donovan C, Pruitt KD, Rawlings ND, Saier M, Sowdhamini R, Spedding M, Srinivasan N, Vriend G, Babbitt PC, Bateman A. (2015) Key challenges for the creation and maintenance of specialist protein resources. Proteins. 83: 1005-13. [PMID:25820941]

Southan C. (2015) Expanding opportunities for mining bioactive chemistry from patents. Drug Discov Today Technol. 14: 3-9 [PMID:26194581]

Lipinski CA, Litterman NK, Southan C, Williams AJ, Clark AM, Ekins S. (2014) Parallel Worlds of Public and Commercial Bioactive Chemistry Data. J Med Chem. 58: 2068–76. [PMID:25415348]

Southan C, Sitzmann M and Muresan S. (2013) Comparing the Chemical Structure and Protein Content of ChEMBL, DrugBank, Human Metabolome Database and the Therapeutic Target Database. Mol Inform. 32: 881-897. [PMID:24533037]

Southan C, Hancock JM. (2013) A tale of two drug targets: the evolutionary history of BACE1 and BACE2. Front Genet. 4: 293. [PMID:24381583]

Olsen RW, Sieghart W. (2009) GABA-A receptors: Subtypes provide diversity of function and pharmacology. Neuropharmacology. 56: 141-148. [PMID:18760291]

Collingridge GL, Olsen RW, Peters J, Spedding M. (2009) A nomenclature for ligand-gated ion channels. Neuropharmacology. 56: 2-5. [PMID:18655795]

Spedding M, Foord SM, Hofmann F. (2004) Current status of drug receptor nomenclature: receptor closure? The role of NC-IUPHAR. Expert Opin Investig Drugs. 13: 461-4. [PMID:15155121]

Fredholm BB, Fleming WW, Vanhoutte PM, Godfraind T. (2002) The role of pharmacology in drug discovery. Nat Rev Drug Discov. 1: 237-8. [PMID:12120508]

Articles describing the NC-IUPHAR database are published in the annual database issue of the journal Nucleic Acids Research. Other articles on topics related to the database are also listed.

For a general citation of the Guide to PHARMACOLOGY portal, please cite the description published in Nucleic Acids Research:

Harding SD, Armstrong JF, Faccenda E, Southan C, Alexander SPH, Davenport AP, Spedding M, Davies JA. (2023) The IUPHAR/BPS Guide to PHARMACOLOGY in 2024. Nucl. Acids Res. 2024; 52(D1):D1438-D1449. doi:10.1093/nar/gkad944. [Full text]. PMID: 37897341.

For further information on citing data in the Guide to PHARMACOLOGY please see this page.

An article published in the magazine of the Biochemical Society describes the vision for the Guide To PHARMACOLOGY portal:

Pawson AJ, Sharman JL, Benson HE, Faccenda E, Spedding M, Harmar AJ. (2013) The Guide to PHARMACOLOGY portal - a one-stop pharmacology shop. The Biochemist. 35 (1): 36-39.

Other articles:

Harding SD, Armstrong JF, Faccenda E, Southan C, Alexander SPH, Davenport AP, Pawson AJ, Spedding M, Davies JA; NC-IUPHAR. (2021) The IUPHAR/BPS guide to PHARMACOLOGY in 2022: curating pharmacology for COVID-19, malaria and antibacterials. Nucl. Acids Res. 50(D1):D1282-D1294. doi: 10.1093/nar/gkab1010. [Full text]. PMID: 34718737.

Harding, S.D., Faccenda, E., Southan, C., Pawson, A.J., Maffia, P., Alexander, S.P.H., Davenport, A.P., Fabbro, D., Levi‐Schaffer, F., Spedding, M. and Davies, J.A. (2020), The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology. Immunology, 160: 10-23. doi:10.1111/imm.13175 [PMID:32020584]

Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Southan C, Sharman JL, Campo B, Cavanagh DR, Alexander SPH, Davenport AP, Spedding M, Davies JA; NC-IUPHAR. (2019) The IUPHAR/BPS Guide to PHARMACOLOGY in 2020: extending immunopharmacology content and introducing the IUPHAR/MMV Guide to MALARIA PHARMACOLOGY. Nucl. Acids Res. Volume 48, Issue D1, D1006-D1021. doi: 10.1093/nar/gkz951. [Full text]. PMID: 31691834

Davies JA, Ireland S, Harding S, Sharman JL, Southan C, Dominguez-Monedero A. (2019). Inverse pharmacology: Approaches and tools for introducing druggability into engineered proteins. Biotechnol Adv 37(8) doi: 10.1016/j.biotechadv.2019.107439. [PMID:31494210]

Harding SD, Faccenda E, Southan C, Maffia P, Davies JA. (2018). A new guide to immunopharmacology. Nat Rev Immunol, 18(12):729. [PMID:30327546]

Ireland SM, Southan C, Dominguez-Monedero, Harding SD, Sharman JL, Davies JA. (2018). SynPharm: A Guide to PHARMACOLOGY Database Tool for Designing Drug Control into Engineered Proteins. ACS Omega, 3 (7), pp 7993–8002, doi: 10.1021/acsomega.8b00659. [PMID:30087931]

Southan C, Sharman JL, Faccenda E, Pawson AJ, Harding SD, Davies JA. (2018). Challenges of Connecting Chemistry to Pharmacology: Perspectives from Curating the IUPHAR/BPS Guide to PHARMACOLOGY. ACS Omega, 3 (7), pp 8408–8420, doi: 10.1021/acsomega.8b00884. [PMID:30087946]

Sharman JL, Harding SD, Southan C, Faccenda E, Pawson AJ, Davies JA; NC-IUPHAR. (2018) Accessing Expert‐Curated Pharmacological Data in the IUPHAR/BPS Guide to PHARMACOLOGY. Curr Protoc Bioinformatics. 61: 1.34.1-1.34.46. [PMID:30040201]

Harding SD, Sharman JL, Faccenda E, Southan C, Pawson AJ, Ireland S, Gray AJG, Bruce L, Alexander SPH, Anderton S, Bryant C, Davenport AP, Doerig C, Fabbro D, Levi-Schaffer F, Spedding M, Davies JA; NC-IUPHAR. (2018) The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY. Nucl. Acids Res. 46 (Issue D1): D1091-D1106. doi: 10.1093/nar/gkx1121. [PMID:29149325]

Southan C, Sharman JL, Benson HE, Faccenda E, Pawson AJ, Alexander SPH, Buneman OP, Davenport AP, McGrath JC, Peters JA, Spedding M, Catterall WA, Fabbro D, Davies JA; NC-IUPHAR. (2016) The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. Nucl. Acids Res. 44 (Database Issue): D1054-68. [PMID:26464438]

Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, Davenport AP, McGrath JC, Peters JA, Southan C, Spedding M, Yu W, Harmar AJ; NC-IUPHAR. (2014) The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands. Nucl. Acids Res. 42 (Database Issue): D1098-106. [PMID:24234439]

Sharman JL, Benson HE, Pawson AJ, Lukito V, Mpamhanga CP, Bombail V, Davenport AP, Peters JA, Spedding M, Harmar AJ; NC-IUPHAR. (2013) IUPHAR-DB: updated database content and new features. Nucl. Acids Res. 41 (Database Issue): D1083-8. [PMID:23087376]

Mpamhanga CP, Sharman JL, Harmar AJ; NC-IUPHAR. (2012) How to Use the IUPHAR Receptor Database to Navigate Pharmacological Data. Methods Mol Biol. 897: 15-29. In Receptor Binding Techniques edited by Anthony P. Davenport (Springer Protocols). [PMID:22674159]

Sharman JL, Mpamhanga CP, Spedding M, Germain P, Staels B, Dacquet C, Laudet V, Harmar AJ; NC-IUPHAR. (2011) IUPHAR-DB: new receptors and tools for easy searching and visualization of pharmacological data. Nucl. Acids Res. 39 (Database Issue): D534-538. [PMID:21087994]

Harmar AJ, Hills RA, Rosser EM, Jones M, Buneman OP, Dunbar DR, Greenhill SD, Hale VA, Sharman JL, Bonner TI, Catterall WA, Davenport AP, Delagrange P, Dollery CT, Foord SM, Gutman GA, Laudet V, Neubig RR, Ohlstein EH, Olsen RW, Peters J, Pin JP, Ruffolo RR, Searls DB, Wright MW, Spedding M. (2009) IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channels. Nucl. Acids Res. 37 (Database Issue): D680-D685. [PMID:18948278]